2 min listen
Inside CAR-T Therapy For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
Inside CAR-T Therapy For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
ratings:
Length:
19 minutes
Released:
Apr 28, 2022
Format:
Podcast episode
Description
Amit Kumar, Ph.D., President and CEO at Anixa Biosciences details the company’s progress on its Phase 1 trial for ovarian cancer. We also discuss why the company’s ovarian cancer program is integral for initial proof of concept for other solid tumor indications. He covers why CAR-T therapy uses an existing hormone/hormone receptor relationship to create a targeted approach to treat ovarian cancer. Dr. Kumar shares how the field of cell therapy may evolve in the short term, and much more.
Released:
Apr 28, 2022
Format:
Podcast episode
Titles in the series (76)
Introducing Cell & Gene: The Podcast by Cell & Gene: The Podcast